Form 4 for AGIO AGIOS PHARMACEUTICALS, INC.
Accepted 2024-12-13 00:00:00 ET · period of report 2024-12-11 · accession 0001439222-24-000146 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-12-13 | 2024-12-11 | AGIO | Scadden David | Dir | S - Sale+OE | $46.28 | -200 | 15.5K | -1% | -$9,256 |
| D | 2024-12-13 | 2024-12-11 | AGIO | Scadden David | Dir | M - OptEx | $18.09 | +200 | 15.7K | +1% | +$3,618 |
| D | 2024-12-13 | 2024-12-11 | AGIO | Scadden David | Dir | M - OptEx | $0.00 | -200 | 29.1K | -0.7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2024-12-11 | S | D | 200 | $46.28 | 15,483 | D | — | — | |
| 2 | Common | Common stock | 2024-12-11 | M | A | 200 | $18.09 | 15,683 | D | — | — | |
| 3 | Derivative | Stock options (right to buy) | 2024-12-11 | M | D | 200 | $0.00 | 29,107 | D | $18.09 · — to 2032-06-21 | 200 Common stock | (F2) This option was granted on June 21, 2022. The shares underlying this option vest 100% one year from grant date. |